SMS Reminders and Treatment Compliance and Efficacy in Patients With FGIDs

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

176 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-30

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effect of SMS follow-up on drug compliance and efficacy in patients with FGIDs has not been reported in the literature. We, therefore, conducted a prospective randomized controlled trial to investigate whether SMS follow-up could improve treatment adherence in patients with FGIDs, which in turn would help symptom relief and improve treatment outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Smartphone Message to Improve the Drug Compliance in Pregnant Women.

NCT04295265

Pregnancy Related

UNKNOWN NA

SMS-Based Follow-Ups to Improve Post-Discharge Surgical Outcomes

NCT03161262

Surgical Site Infection

COMPLETED NA

Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda

NCT01579214

HIV Tuberculosis

COMPLETED NA

A Mobile Phone Based Medication Reminder Program

NCT02793830

Medication Adherence

COMPLETED NA

Improving Medication Adherence Through SMS (Short Messaging Service) in Adult Stroke Patients: a Randomised Controlled Behaviour Intervention Trial

NCT01986023

Medication Adherence Stroke

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The irritable bowel syndrome (IBS) and other functional gastrointestinal disorders (FGIDs) are common and pose significant burdens to patients. Although regular medications have substantial benefits for disease remission, many patients do not follow the recommendations of standard medication regimens given by physicians at the time of the visit, so how to improve patient compliance becomes even more important. Many factors can affect drug compliance. Forgetting seems to be one of the important reasons for poor compliance. In order to solve this problem, many studies such as drug charts/calendars, mini kits, etc. have been conducted in previous studies. At present, with the popularization of mobile phones, SMS-based interventions are gradually being applied to various medical environments. Compared with the phone, SMS consumes less time and can be easily integrated into the patient's daily life. Therefore, short messages may be more suitable for follow-up of patients outside hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Functional Gastrointestinal Disorders Patient Compliance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

The control group

Patients in this group only received medications without daily text message reminder

Group Type NO_INTERVENTION

No interventions assigned to this group

The intervention group

Patients in this group received a daily short message service (SMS) reminder when medications were prescribed

Group Type EXPERIMENTAL

SMS follow-up

Intervention Type BEHAVIORAL

In addition to conventional treatment, the experimental group received SMS reminding every day until the end of the treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SMS follow-up

In addition to conventional treatment, the experimental group received SMS reminding every day until the end of the treatment.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with newly diagnosed FGIDs according to Rome-IV
* Aged 18-70 years
* With no obvious organic abnormalities

Exclusion Criteria

* With organic gastrointestinal diseases
* With psychiatric diseases or are taking psychotropic agents
* With severe cardiopulmonary or other organ diseases
* Pregnant women

Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No